AiCuris along with Prof. Dr. Dr. H.C. Waldmann, Director of the Chemical Biology Department at MPI, will jointly investigate and optimize antibacterial or antiviral compounds, which could be developed into anti-infective drugs.
“We welcome this strong support from a group of experienced and successful investors who understand the need and market opportunity for new medicines to combat multi drug-resistant bacterial infections”
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.